| dc.creator | Poulou, L. S. | en |
| dc.creator | Ziakas, P. D. | en |
| dc.creator | Ziogas, D. C. | en |
| dc.creator | Doxani, C. | en |
| dc.creator | Xyla, V. | en |
| dc.creator | Vakrinos, G. | en |
| dc.creator | Voulgarelis, M. | en |
| dc.creator | Thanos, L. | en |
| dc.date.accessioned | 2015-11-23T10:46:00Z | |
| dc.date.available | 2015-11-23T10:46:00Z | |
| dc.date.issued | 2012 | |
| dc.identifier | 10.3109/1354750x.2012.699553 | |
| dc.identifier.issn | 1354-750X | |
| dc.identifier.uri | http://hdl.handle.net/11615/32436 | |
| dc.description.abstract | Context: Scanty reports have focused on FDG-PET after radiofrequency ablation (RFA), for recurrence of hepatic metastases. Objective: To assess FDG-PET diagnostic accuracy on detection of recurrent hepatic lesions. Methods: After a comprehensive search of PubMed and EMBASE, we performed a patient-based diagnostic meta-analysis of post-RFA FDG-PET. Results: Across nine included articles, independent, random-effects sensitivity and specificity were 0.73(0.50-0.88) and 0.85(0.72-0.93), respectively. A symmetrical SROC curve was produced with no significant heterogeneity. Specificity was optimal for surgical RFA and colorectal origin of metastases. Conclusion: Synthesis of published evidence suggests PET/CT as an appropriate tool for optimizing post-ablation follow-up. | en |
| dc.source | Biomarkers | en |
| dc.source.uri | <Go to ISI>://WOS:000308142000008 | |
| dc.subject | Radiofrequency ablation | en |
| dc.subject | positron emission tomography | en |
| dc.subject | metastasis | en |
| dc.subject | meta-analysis | en |
| dc.subject | POSITRON-EMISSION-TOMOGRAPHY | en |
| dc.subject | RADIOFREQUENCY THERMAL ABLATION | en |
| dc.subject | COLORECTAL-CANCER | en |
| dc.subject | HEPATIC-TUMORS | en |
| dc.subject | FOLLOW-UP | en |
| dc.subject | CT | en |
| dc.subject | MANAGEMENT | en |
| dc.subject | TISSUE | en |
| dc.subject | PERFORMANCE | en |
| dc.subject | CARCINOMA | en |
| dc.subject | Biotechnology & Applied Microbiology | en |
| dc.subject | Toxicology | en |
| dc.title | FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis | en |
| dc.type | journalArticle | en |
